Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Immupharma (IMM) Regulatory News

Date Source Headline
10th Jul 2018 4:40 pm RNS Second Price Monitoring Extn
10th Jul 2018 4:35 pm RNS Price Monitoring Extension
28th Jun 2018 12:16 pm RNS Result of AGM
14th Jun 2018 7:00 am RNS Results of CIDP Pre-Clinical Data
6th Jun 2018 7:00 am RNS Notice of AGM & Posting of Annual Report
29th May 2018 7:00 am RNS Update on Pivotal Phase III Trial of Lupuzor
29th May 2018 7:00 am RNS Final Results
24th Apr 2018 11:59 am RNS Holding(s) in Company
20th Apr 2018 8:24 am RNS Holding(s) in Company
19th Apr 2018 8:05 am RNS Holding(s) in Company
17th Apr 2018 7:00 am RNS Topline results of Lupuzor Pivotal Phase III Trial
28th Mar 2018 7:00 am RNS Appointment of Joint Broker
23rd Mar 2018 7:00 am RNS Lupuzor Pivotal Phase III Study Update
5th Mar 2018 4:13 pm RNS AIM Notice (17)
15th Feb 2018 7:00 am RNS London Investor Evening
9th Feb 2018 2:00 pm RNS Holding(s) in Company
7th Feb 2018 9:35 am RNS Holding(s) in Company
5th Feb 2018 7:00 am RNS Holding(s) in Company
31st Jan 2018 10:23 am RNS Holding(s) in Company
24th Jan 2018 7:00 am RNS Successful Placing to Raise £10 Million
18th Jan 2018 7:00 am RNS Completion of LupuzorT Pivotal Phase III Study
21st Dec 2017 7:05 am RNS Grant of Options
21st Dec 2017 7:00 am RNS Last patient completes dosing in LupuzorT Trial
28th Nov 2017 12:00 pm RNS Holding(s) in Company
24th Nov 2017 1:32 pm RNS Grant of Options
2nd Nov 2017 7:00 am RNS Update on LupuzorT Pivotal Phase III Study
16th Oct 2017 3:29 pm RNS Holding(s) in Company
4th Oct 2017 7:00 am RNS Completion of Lanstead Sharing Agreement
27th Sep 2017 7:00 am RNS Interim Results
26th Sep 2017 7:00 am RNS Preparation of Lupuzor'sT Regulatory Submissions
21st Sep 2017 7:00 am RNS Update on LupuzorT Pivotal Phase III Study
19th Sep 2017 7:00 am RNS Notification of Interim Results
18th Aug 2017 5:09 pm RNS AIM Rule 17 Notice
12th Jul 2017 11:00 am RNS Grant of Options
30th Jun 2017 12:04 pm RNS Result of AGM
30th Jun 2017 7:00 am RNS Update on LupuzorT Pivotal Phase III Study
7th Jun 2017 7:00 am RNS Annual Report & Notice of AGM
1st Jun 2017 7:00 am RNS Final Results
22nd May 2017 7:00 am RNS Notification of Full Year Results
17th May 2017 7:00 am RNS Update on Lupuzor Phase III Study
FTSE 100 Latest
Value8,879.01
Change69.27